Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Takeda Pharmaceutical Co. Ltd.
Current Parent CompanyTakeda Pharmaceutical
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $2,400,000,000
Year: 2015
Date: April 27, 2015
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Violation Description: In April 2015 Takeda announced that it would put up to $2.4 billion into a fund to settle multi-district litigation alleging that its diabetes drug Actos increased the risk of bladder cancer: (click here)
Level of Government: federal
Action Type: private litigation
Court: Western District of Louisiana
Civil or Criminal Case: civil
Case ID: 6:11md2299
Case Name: In Re: Actos (Pioglitazone) Products Liability Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.